Analyst firms · Wedbush · CHWY
Wedbush CHWY price target and rating history
Chewy Inc. (CHWY) · Consumer Discretionary
Wedbush rates Chewy Inc. (CHWY) Outperform with a $31 price target, as of its latest action on Aug 25, 2023. It has published 5 rating actions on CHWY since December 2021, including 2 upgrades and 2 downgrades. Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
- Current rating
- Outperform
- Price target
- $31
- Median target, all firms
- $25
- Actions on CHWY
- 5
Wedbush price target on CHWY
Every Wedbush rating on CHWY
- Aug 25, 2023
- Jan 27, 2023
- Jul 26, 2022
- Jun 21, 2022
- Dec 6, 2021
How other firms rate CHWY
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Hold | $22 | Nov 17, 2026 |
| Evercore ISI | In-line | $25 | Sep 10, 2026 |
| Rosenblatt | Neutral | $25 | Aug 20, 2026 |
| MoffettNathanson | Neutral | Jun 11, 2026 | |
| Raymond James | Outperform | $28 | Feb 19, 2026 |
Questions about Wedbush and CHWY
- What is Wedbush's price target for CHWY?
- Wedbush's latest stated price target for Chewy Inc. (CHWY) is $31, from its action on Aug 25, 2023.
- What is Wedbush's rating on CHWY?
- Wedbush rates CHWY Outperform, a bullish rating, as of Aug 25, 2023.
- When did Wedbush last change its view on CHWY?
- On Aug 25, 2023, Wedbush cuts its price target to $31 from $45, keeps Outperform.
- How does Wedbush's CHWY target compare with other analysts?
- Across 4 firms with a CHWY price target in the last 12 months, the median target is $25.
More CHWY rating histories
- Evercore ISI3
- MoffettNathanson3
- Raymond James3
- Deutsche Bank3
- Mizuho4
- Jefferies4
- Argus Research4
- Wolfe Research4
- BNP Paribas Exane3
- Citigroup3
- Needham4
- Piper Sandler4
- Barclays4
- Goldman Sachs4
- Morgan Stanley4
- UBS3
- Oppenheimer3
- Robert W. Baird3
All Wedbush ratingsCHWY news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.